Vasospasm after aneurysmal subarachnoid hemorrhage: Review of randomized controlled trials and meta-analyses in the literature

World Neurosurgery

Volumn 76, Issue 5, 2011, Pages 446-454

  Velat, Gregory J ^a   Kimball, Matthew M ^a   Mocco, J D ^a   Hoh, Brian L ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aneurysm; Cerebral vasospasm; Delayed ischemic neurologic deficit; Subarachnoid hemorrhage

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CLAZOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; FASUDIL; FIBRINOLYTIC AGENT; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; NICARDIPINE; NIMODIPINE; OZAGREL; PLACEBO; PRAVASTATIN; TAK 044; TIRILAZAD; UROKINASE;

ARTICLE; BRAIN VASOSPASM; CONTINUOUS INFUSION; DRUG COST; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; HYPOCALCEMIA; HYPOTENSION; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE;

EID: 82955242474     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2011.02.030     Document Type: Review

References (63)

1. G.S. Allen, H.S. Ahn, T.J. Preziosi, R. Battye, S.C. Boone, S.N. Chou, D.L. Kelly, B.K. Weir, R.A. Crabbe, P.J. Lavik, S.B. Rosenbloom, F.C. Dorsey, C.R. Ingram, D.E. Mellits, L.A. Bertsch, D.P. Boisvert, M.B. Hundley, R.K. Johnson, J.A. Strom, and C.R. Transou Cerebral arterial spasma controlled trial of nimodipine in patients with subarachnoid hemorrhage N Engl J Med 308 1983 619 624
2. S. Amin-Hanjani, C.S. Ogilvy, and F.G. Barker 2nd Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis Neurosurgery 54 2004 326 334 discussion 334-335
3. T. Asano, K. Takakura, K. Sano, H. Kikuchi, H. Nagai, I. Saito, A. Tamura, C. Ochiai, and T. Sasaki Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial J Neurosurg 84 1996 792 803
4. F.G. Barker 2nd, and C.S. Ogilvy Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis J Neurosurg 84 1996 405 414
5. M. Barth, H.H. Capelle, E. Munch, C. Thome, F. Fiedler, P. Schmiedek, and P. Vajkoczy Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhagepreliminary results from a randomized clinical series Acta Neurochir (Wien) 149 2007 911 918 discussion 918
6. M. Barth, H.H. Capelle, S. Weidauer, C. Weiss, E. Munch, C. Thome, T. Luecke, P. Schmiedek, H. Kasuya, and P. Vajkoczy Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study Stroke 38 2007 330 336
7. R.Y. Chia, R.S. Hughes, and M.K. Morgan Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage J Clin Neurosci 9 2002 279 281
8. S.H. Chou, E.E. Smith, N. Badjatia, R.G. Nogueira, J.R. Sims 2nd, C.S. Ogilvy, G.A. Rordorf, and C. Ayata A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage Stroke 39 2008 2891 2893
9. S.M. Dorhout Mees, G.J. Rinkel, V.L. Feigin, A. Algra, W.M. van den Bergh, M. Vermeulen, and J. van Gijn Calcium antagonists for aneurysmal subarachnoid haemorrhage Cochrane Database Syst Rev 2007 CD000277
10. A. Egge, K. Waterloo, H. Sjoholm, T. Solberg, T. Ingebrigtsen, and B. Romner Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study Neurosurgery 49 2001 593 605 discussion 605-606
11. V.L. Feigin, G.J. Rinkel, A. Algra, M. Vermeulen, and J. van Gijn Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review Neurology 50 1998 876 883
12. J.M. Findlay, N.F. Kassell, B.K. Weir, E.C. Haley Jr, G. Kongable, T. Germanson, L. Truskowski, W.M. Alves, R.O. Holness, N.W. Knuckey, H. Yonus, G.K. Steinberg, M. West, H.R. Winn, and G. Ferguson A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm Neurosurgery 37 1995 168 176 discussion 177-178
13. C.M. Fisher, G.H. Roberson, and R.G. Ojemann Cerebral vasospasm with ruptured saccular aneurysmthe clinical manifestations Neurosurgery 1 1977 245 248
14. E.C. Haley Jr, N.F. Kassell, C. Apperson-Hansen, M.H. Maile, and W.M. Alves A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America J Neurosurg 86 1997 467 474
15. E.C. Haley Jr, N.F. Kassell, and J.C. Torner The International Cooperative Study on the Timing of Aneurysm Surgery The North American experience Stroke 23 1992 205 214
16. E.C. Haley Jr, N.F. Kassell, and J.C. Torner A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage A report of the Cooperative Aneurysm Study J Neurosurg 78 1993 537 547
17. J. Hamada, Y. Kai, M. Morioka, S. Yano, T. Mizuno, T. Hirano, K. Kazekawa, and Y. Ushio Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study Stroke 34 2003 2549 2554
18. R.C. Heros, N.T. Zervas, and V. Varsos Cerebral vasospasm after subarachnoid hemorrhage: an update Ann Neurol 14 1983 599 608
19. J.W. Hop, G.J. Rinkel, A. Algra, and J. van Gijn Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review Stroke 28 1997 660 664
20. M. Jan, F. Buchheit, and M. Tremoulet Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms Neurosurgery 23 1988 154 157
21. Y.G. Jang, D. Ilodigwe, and R.L. Macdonald Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage Neurocrit Care 10 2009 141 147
22. P. Karinen, P. Koivukangas, A. Ohinmaa, J. Koivukangas, and J. Ohman Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery Neurosurgery 45 1999 780 784 discussion 784-785
23. N.F. Kassell, E.C. Haley Jr, C. Apperson-Hansen, and W.M. Alves Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand J Neurosurg 84 1996 221 228
24. J.T. King Jr Epidemiology of aneurysmal subarachnoid hemorrhage Neuroimaging Clin N Am 7 1997 659 668
25. G. Lanzino, and N.F. Kassell Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage Part II. A cooperative study in North America J Neurosurg 90 1999 1018 1024
26. G. Lanzino, N.F. Kassell, N.W. Dorsch, A. Pasqualin, L. Brandt, P. Schmiedek, L.L. Truskowski, and W.M. Alves Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa J Neurosurg 90 1999 1011 1017
27. L. Lennihan, S.A. Mayer, M.E. Fink, A. Beckford, M.C. Paik, H. Zhang, Y.C. Wu, L.M. Klebanoff, E.C. Raps, and R.A. Solomon Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial Stroke 31 2000 383 391
28. W.T. Longstreth Jr, L.M. Nelson, T.D. Koepsell, and G. van Belle Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington Neurology 43 1993 712 718
29. J.R. Lynch, H. Wang, M.J. McGirt, J. Floyd, A.H. Friedman, A.L. Coon, R. Blessing, M.J. Alexander, C. Graffagnino, D.S. Warner, and D.T. Laskowitz Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial Stroke 36 2005 2024 2026
30. R.L. Macdonald, N.F. Kassell, S. Mayer, D. Ruefenacht, P. Schmiedek, S. Weidauer, A. Frey, S. Roux, and A. Pasqualin Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial Stroke 39 2008 3015 3021
31. M.J. McGirt, G.F. Woodworth, G. Pradilla, F. Legnani, D. Warner, R. Tamargo, R. Clatterbuck, J.R. Lynch, and D.T. Laskowitz Galbraith Award: simvastatin attenuates experimental cerebral vasospasm and ameliorates serum markers of neuronal and endothelial injury in patients after subarachnoid hemorrhage: a dose-response effect dependent on endothelial nitric oxide synthase Clin Neurosurg 52 2005 371 378
32. K. Messeter, L. Brandt, B. Ljunggren, N.A. Svendgaard, L. Algotsson, B. Romner, and E. Ryding Prediction and prevention of delayed ischemic dysfunction after aneurysmal subarachnoid hemorrhage and early operation Neurosurgery 20 1987 548 553
33. A. Munakata, H. Ohkuma, T. Nakano, N. Shimamura, K. Asano, and M. Naraoka Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage Neurosurgery 64 2009 423 428 discussion 428-429
34. C. Muroi, A. Terzic, M. Fortunati, Y. Yonekawa, and E. Keller Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial Surg Neurol 69 2008 33 39 discussion 39
35. G. Neil-Dwyer, E. Mee, D. Dorrance, and D. Lowe Early intervention with nimodipine in subarachnoid haemorrhage Eur Heart J 8 Suppl K 1987 41 47
36. J. Ohman, A. Servo, and O. Heiskanen Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery J Neurosurg 74 1991 8 13
37. K.C. Petruk, M. West, G. Mohr, B.K. Weir, B.G. Benoit, F. Gentili, L.B. Disney, M.I. Khan, M. Grace, R.O. Holness, M.S. Karwon, R.M. Ford, G.S. Cameron, W.S. Tucker, G.B. Purves, J.D. Miller, K.M. Hunter, M.T. Richard, F.A. DUrity, R. Chan, L.J. Clein, F.B. Maroun, and A. Godon Nimodipine treatment in poor-grade aneurysm patients Results of a multicenter double-blind placebo-controlled trial J Neurosurg 68 1988 505 517
38. J. Philippon, R. Grob, F. Dagreou, M. Guggiari, M. Rivierez, and P. Viars Prevention of vasospasm in subarachnoid haemorrhage A controlled study with nimodipine Acta Neurochir (Wien) 82 1986 110 114
39. J.D. Pickard, G.D. Murray, R. Illingworth, M.D. Shaw, G.M. Teasdale, P.M. Foy, P.R. Humphrey, D.A. Lang, R. Nelson, P. Richards, J. Sinar, S. Bailey, and A. Skene Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial BMJ 298 1989 636 642
40. G.J. Rinkel, V.L. Feigin, A. Algra, W.M. van den Bergh, M. Vermeulen, and J. van Gijn Calcium antagonists for aneurysmal subarachnoid haemorrhage Cochrane Database Syst Rev 2005 CD000277
41. R.H. Rosenwasser, T.E. Delgado, W.A. Buchheit, and M.H. Freed Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report Neurosurgery 12 1983 658 661
42. I. Saito, T. Asano, K. Sano, K. Takakura, H. Abe, T. Yoshimoto, H. Kikuchi, T. Ohta, and S. Ishibashi Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage Neurosurgery 42 1998 269 277 discussion 277-278
43. M.D. Shaw, M. Vermeulen, G.D. Murray, J.D. Pickard, B.A. Bell, and G.M. Teasdale Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group J Neurosurg 93 2000 992 997
44. M. Shibuya, Y. Suzuki, K. Sugita, I. Saito, T. Sasaki, K. Takakura, I. Nagata, H. Kikuchi, T. Takemae, H. Hidaka, and M. Nakashima Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage Results of a prospective placebo-controlled double-blind trial J Neurosurg 76 1992 571 577
45. J. Siironen, S. Juvela, J. Varis, M. Porras, K. Poussa, S. Ilveskero, J. Hernesniemi, and R. Lassila No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial J Neurosurg 99 2003 953 959
46. V.A. Sillberg, G.A. Wells, and J.J. Perry Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis Stroke 39 2008 2622 2626
47. J.B. Springborg, C. Moller, P. Gideon, O.S. Jorgensen, M. Juhler, and N.V. Olsen Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial Acta Neurochir (Wien) 149 2007 1089 1101 discussion 1101
48. B. Stegmayr, M. Eriksson, and K. Asplund Declining mortality from subarachnoid hemorrhage: changes in incidence and case fatality from 1985 through 2000 Stroke 35 2004 2059 2063
49. M. Stippler, E. Crago, E.I. Levy, M.E. Kerr, H. Yonas, M.B. Horowitz, and A. Kassam Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage J Neurosurg 105 2006 723 729
50. S. Suzuki, K. Sano, H. Handa, T. Asano, A. Tamura, Y. Yonekawa, H. Ono, N. Tachibana, and K. Hanaoka Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study Neurol Res 11 1989 79 88
51. M.M. Treggiari, B. Walder, P.M. Suter, and J.A. Romand Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage J Neurosurg 98 2003 978 984
52. S.A. Tsementzis, E.R. Hitchcock, and C.H. Meyer Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms A double-blind placebo-controlled study Acta Neurochir (Wien) 102 1990 1 10
53. M.Y. Tseng, M. Czosnyka, H. Richards, J.D. Pickard, and P.J. Kirkpatrick Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial Stroke 36 2005 1627 1632
54. M.Y. Tseng, P.J. Hutchinson, H.K. Richards, M. Czosnyka, J.D. Pickard, W.N. Erber, S. Brown, and P.J. Kirkpatrick Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial Clinical article J Neurosurg 111 2009 171 180
55. P. Vajkoczy, B. Meyer, S. Weidauer, A. Raabe, C. Thome, F. Ringel, V. Breu, and P. Schmiedek Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study J Neurosurg 103 2005 9 17
56. W.M. van den Bergh, A. Algra, F. van Kooten, C.M. Dirven, J. van Gijn, M. Vermeulen, and G.J. Rinkel Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial Stroke 36 2005 1011 1015
57. M.D. Vergouwen, J.C. Meijers, R.B. Geskus, B.A. Coert, J. Horn, E.S. Stroes, T. van der Poll, M. Vermeulen, and Y.B. Roos Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial J Cereb Blood Flow Metab 29 2009 1444 1453
58. R.S. Veyna, D. Seyfried, D.G. Burke, C. Zimmerman, M. Mlynarek, V. Nichols, A. Marrocco, A.J. Thomas, P.D. Mitsias, and G.M. Malik Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage J Neurosurg 96 2002 510 514
59. G.K. Wong, M.T. Chan, R. Boet, W.S. Poon, and T. Gin Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study J Neurosurg Anesthesiol 18 2006 142 148
60. G. Wurm, B. Tomancok, K. Nussbaumer, C. Adelwohrer, and K. Holl Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo Clin Neurol Neurosurg 106 2004 97 103
61. J. Zhao, D. Zhou, J. Guo, Z. Ren, L. Zhou, S. Wang, B. Xu, and R. Wang Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage Neurol Med Chir (Tokyo) 46 2006 421 428
62. X.D. Zhao, Y.T. Zhou, X. Zhang, Z. Zhuang, and J.X. Shi A meta analysis of treating subarachnoid hemorrhage with magnesium sulfate J Clin Neurosci 16 2009 1394 1397
63. M. Zwienenberg-Lee, J. Hartman, N. Rudisill, L.K. Madden, K. Smith, J. Eskridge, D. Newell, B. Verweij, M.R. Bullock, A. Baker, W. Coplin, R. Mericle, J. Dai, D. Rocke, and J.P. Muizelaar Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial Stroke 39 2008 1759 1765